Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce W Bode

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Diabetes/Metabolism Research and Reviews|March 29, 2002
Diabetes management in the new millennium using insulin pump therapyBruce W Bode, Hassan T Sabbah, Todd M Gross, et al.
Diabetes Technology & Therapeutics|July 10, 2020
Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump StudyBruce W Bode, Satish K Garg, Paul Norwood, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Use of a computerized intravenous insulin algorithm within a nurse-directed protocol for patients undergoing cardiovascular surgeryPaul C Davidson, R Dennis Steed, Bruce W Bode, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 23, 2023
Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 DiabetesRichard M Bergenstal, Bruce W Bode, Anuj Bhargava, et al.
Drugs - Real World Outcomes|December 14, 2019
Effectiveness of V-Go<sup>®</sup> for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational StudyGeorge Grunberger, Cheryl R Rosenfeld, Bruce W Bode, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Diabetes Care|July 12, 2014
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetesRonnie Aronson, Peter A Gottlieb, Jens S Christiansen, et al.
Diabetes Care|July 17, 2015
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week TrialBruce W Bode, Janet B McGill, Daniel L Lorber, et al.
Diabetes Technology & Therapeutics|July 10, 2010
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimenSteven V Edelman, Bruce W Bode, Timothy S Bailey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2014
Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare)Bruce W Bode, Louis B Chaykin, Allen M Sussman, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Diabetes/Metabolism Research and Reviews|March 29, 2002
Diabetes management in the new millennium using insulin pump therapyBruce W Bode, Hassan T Sabbah, Todd M Gross, et al.
Diabetes Technology & Therapeutics|July 10, 2020
Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump StudyBruce W Bode, Satish K Garg, Paul Norwood, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Use of a computerized intravenous insulin algorithm within a nurse-directed protocol for patients undergoing cardiovascular surgeryPaul C Davidson, R Dennis Steed, Bruce W Bode, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 23, 2023
Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 DiabetesRichard M Bergenstal, Bruce W Bode, Anuj Bhargava, et al.
Drugs - Real World Outcomes|December 14, 2019
Effectiveness of V-Go<sup>®</sup> for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational StudyGeorge Grunberger, Cheryl R Rosenfeld, Bruce W Bode, et al.
Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.
Diabetes Care|July 12, 2014
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetesRonnie Aronson, Peter A Gottlieb, Jens S Christiansen, et al.
Diabetes Care|July 17, 2015
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week TrialBruce W Bode, Janet B McGill, Daniel L Lorber, et al.
Diabetes Technology & Therapeutics|July 10, 2010
Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimenSteven V Edelman, Bruce W Bode, Timothy S Bailey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2014
Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare)Bruce W Bode, Louis B Chaykin, Allen M Sussman, et al.
Pageof 13